The new round of funding for the $22.3 million Biomedical Translation Bridge (BTB) program is now open.
The third round of the BTB program (COVID-19 Response) is open from Monday 18 May to Monday 1 June 2020.
In this specific COVID-19 call, the BTB Program can provide up to $1million to support eligible organisations develop medical devices, diagnostics, prophylactic or therapeutic approaches that will achieve an impact on the global response to the pandemic in less than 12 months.
Funding will support Australian small and medium enterprises, medical research institutes and universerities conducting COVID-19 related research projects.
Applicants will be required to provide one-to-one matching funding in the form of cash to be eligible.
For full details of the guidelines and application process visit the MTPConnect website.
MTPConnect is delivering the BTB program in partnership with BioCurate (Melbourne and Monash Universities), UniQuest (University of Queensland), the Medical Device Partnering Program (led by Flinders University) and the Bridge and BridgeTech programs (Queensland University of Technology).